SMAA yields 20000000.00% · JNJ yields 2.13%● Live data
📍 SMAA pulled ahead of the other in Year 1
Combined, SMAA + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SMAA + JNJ for your $10,000?
SMA Alliance, Inc. provides marketing and advertising solutions. It offers Internet focused lead generator, which drives live buyers to retailers through conversion of individual online product interest into live buyers soliciting purchase from retailers. The company focuses on the automobile industry, providing automobile retailers buying demand on a daily basis through application of proprietary technology and managed systems. Its services include used car classified posting; new car inventory classified posting; search engine saturation by producing and hosting micro/mobile sites and mobile apps; creation, customization, or clean up of dealership professional's social media pages; enhances the visibility of a dealership's news and events to search engines, as well as builds links for dealership Website; and self service classified posting. The company's services also comprise sales, phone, and Internet training on site or on demand; generating automotive credit leads for dealership from dealership specific inventory; generating credit filter leads; and call center services for the fulfillment of lead generation campaigns. It serves as a marketing and advertising vendor to retailers primarily in the automobiles, real estate, employment recruitment, travel, and government sectors. SMA Alliance, Inc. was incorporated in 1969 and is based in Newport News, Virginia.
Full SMAA Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.